Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01096810 · OUTCOME

Antitumor Effect

Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma · Source last updated 2016-07-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Antitumor effect

What was measured

To study the possible mechanisms involved in the clinical antitumor effect with determination of inhibition of angiogenesis

Analysis population: immunophenotyping was not performed in this study

Groups in this outcome

TBL 12

TBL 12, sea cucumber, will be administered orally at a dose of 2 units (20 mL each) twice a day until disease progression

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
TBL 120

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
To study the possible mechanisms involved in the clinical antitumor effect with determination of inhibition of angiogenesis
groups
  1. description
    TBL 12, sea cucumber, will be administered orally at a dose of 2 units (20 mL each) twice a day until disease progression
    id
    OG000
    title
    TBL 12
population Description
immunophenotyping was not performed in this study
reporting Status
POSTED
time Frame
Antitumor effect
title
Antitumor Effect
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice